Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Hee Lim

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Cancer Research and Treatment|January 16, 2024
Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective StudyJunho Lee, Sung Hee Lim, Jae Hoon Chung, et al.
Journal of Gastric Cancer|August 8, 2023
The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric CancerJae Yeon Jang, Youngkyung Jeon, Sun Young Jeong, et al.
Journal for Immunotherapy of Cancer|September 30, 2025
Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapySung Hee Lim, Takeshi Kuwata, Minae An, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 6, 2026
Integrative Molecular Analysis to Predict Clinical Benefit of Everolimus in Patients With Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP-NETs)Miran Han, Eunbyeol Lee, Ji Eun Shin, et al.
Journal of Korean Medical Science|September 12, 2023
Is Treosulfan-Based Conditioning Attractive as a Reduced-Intensity Conditioning Regimen in Korea?Se Hyung Kim, Young Sok Ji, Jina Yun, et al.
Therapeutic Advances in Medical Oncology|January 30, 2026
Prognostic value of ctDNA-derived maximum somatic allele frequency in patients with metastatic gastric cancerChanggon Kim, Young-Gon Kim, Jihwan Moon, et al.
Asia-Pacific Journal of Clinical Oncology|April 7, 2023
Comparison of antibody response to coronavirus disease 2019 vaccination between patients with solid or hematologic cancer patients undergoing chemotherapySung Hee Lim, Seong Hyeok Choi, Young Sok Ji, et al.
Plos One|February 23, 2016
The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)Ji Yun Lee, Sung Hee Lim, Min-Young Lee, et al.
Oncology Research|December 30, 2024
Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumabRyul Kim, Joo Kyung Park, Minsuk Kwon, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 22, 2026
Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapyChanggon Kim, Junkyu Kim, Ji Eun Shin, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Cancer Research and Treatment|January 16, 2024
Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective StudyJunho Lee, Sung Hee Lim, Jae Hoon Chung, et al.
Journal of Gastric Cancer|August 8, 2023
The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric CancerJae Yeon Jang, Youngkyung Jeon, Sun Young Jeong, et al.
Journal for Immunotherapy of Cancer|September 30, 2025
Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapySung Hee Lim, Takeshi Kuwata, Minae An, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 6, 2026
Integrative Molecular Analysis to Predict Clinical Benefit of Everolimus in Patients With Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP-NETs)Miran Han, Eunbyeol Lee, Ji Eun Shin, et al.
Journal of Korean Medical Science|September 12, 2023
Is Treosulfan-Based Conditioning Attractive as a Reduced-Intensity Conditioning Regimen in Korea?Se Hyung Kim, Young Sok Ji, Jina Yun, et al.
Therapeutic Advances in Medical Oncology|January 30, 2026
Prognostic value of ctDNA-derived maximum somatic allele frequency in patients with metastatic gastric cancerChanggon Kim, Young-Gon Kim, Jihwan Moon, et al.
Asia-Pacific Journal of Clinical Oncology|April 7, 2023
Comparison of antibody response to coronavirus disease 2019 vaccination between patients with solid or hematologic cancer patients undergoing chemotherapySung Hee Lim, Seong Hyeok Choi, Young Sok Ji, et al.
Plos One|February 23, 2016
The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)Ji Yun Lee, Sung Hee Lim, Min-Young Lee, et al.
Oncology Research|December 30, 2024
Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumabRyul Kim, Joo Kyung Park, Minsuk Kwon, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 22, 2026
Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapyChanggon Kim, Junkyu Kim, Ji Eun Shin, et al.
Pageof 11